---
title: "GRANDE ALICIA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/57b98111-6fcb-530e-bc2d-e8b6eb59c91b
json: https://whiteintel.dev/api/public/dossier/57b98111-6fcb-530e-bc2d-e8b6eb59c91b
identifier: sec:0001402652
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GRANDE ALICIA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001402652`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/57b98111-6fcb-530e-bc2d-e8b6eb59c91b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/57b98111-6fcb-530e-bc2d-e8b6eb59c91b  

## Ownership & control

### Holdings / subsidiaries

- **CATALYST PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/b1cd460a-81b5-57a2-b42b-dac6718ca97d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GRANDE ALICIA**. Human view: https://whiteintel.dev/entity/57b98111-6fcb-530e-bc2d-e8b6eb59c91b · Structured JSON: https://whiteintel.dev/api/public/dossier/57b98111-6fcb-530e-bc2d-e8b6eb59c91b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._